Ceftazidime-Avibactam in Combination With Fosfomycin: A Novel Therapeutic Strategy Against Multidrug-Resistant Pseudomonas aeruginosa

Previously, by targeting penicillin-binding protein 3, Pseudomonas-derived cephalosporinase (PDC), and MurA with ceftazidime-avibactam-fosfomycin, antimicrobial susceptibility was restored among multidrug-resistant (MDR) Pseudomonas aeruginosa. Herein, ceftazidime-avibactam-fosfomycin combination th...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Infect Dis
Main Authors: Papp-Wallace, Krisztina M, Zeiser, Elise T, Becka, Scott A, Park, Steven, Wilson, Brigid M, Winkler, Marisa L, D’Souza, Roshan, Singh, Indresh, Sutton, Granger, Fouts, Derrick E, Chen, Liang, Kreiswirth, Barry N, Ellis-Grosse, Evelyn J, Drusano, George L, Perlin, David S, Bonomo, Robert A
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2019
Assuntos:
Major Articles and Brief Reports
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6639593/
https://ncbi.nlm.nih.gov/pubmed/31099835
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/infdis/jiz149
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados